bpc-157 fda compounding category Peptide Review 2026: What This Big Shift Means Peptides in the Limelight: US

Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA Compliance for Peptide Therapy and BPC 157 Holt Law HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer FDA Advisory Committee Recommends Adding BPC 157 to Compounding List American Med Spa Association FDA Peptide Update: Category 2 Removals Explained

SKU: 9948999733 · From metron-ms.com